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The impact of viral co-circulation is still little known. As in the case of reinfection by different serotypes of DENV, the interaction of arboviruses (dengue serotypes 1-4, CHIKV, and ZIKV) could theoretically result in more intense viremia or other immunological changes 5 that could trigger autoimmune diseases, such as Guillain-Barré syndrome.
The association of microcephaly cases with the infection of pregnant women by ZIKV was recently presented through virological and pathological fetal images and analyses 6 , and confirmed by Brazilian studies through virus identification and sequencing in amniotic fluid from two women who had the infection during pregnancy and fetuses with microcephaly 7, 8 . Although microcephaly is linked to many environmental and genetic exposures, drug use during pregnancy, infections such as rubella, toxoplasmosis, and cytomegalovirus, among others, the association with ZIKV infection follows the increase of cases of microcephaly and other neurological malformations in Brazil since 2015 9 . Until March 12, 2016, the Emergency Operations Center in Public Health on Microcephaly of the Brazilian Ministry of Health (MOH) announced the confirmation of 863 cases of microcephaly and/or alteration of the central nervous system (CNS), which suggest congenital infection, still based on the previous criteria for head circumference of 32 cm for newborns with 37 or more weeks of gestation 10 . On March 10, the cutoff point was reduced to 31.9 cm for boys and 31.5 cm for girls. The investigation of 6,680 cases of microcephaly already ruled out 1,349 of them, with 97 cases of microcephaly and other neurological disorders confirmed by specific laboratory criteria for ZIKV (PCR technique and serology) 10 . Other hypotheses, never confirmed, have been suggested to explain the increase in microcephaly cases, including the assumption that this and other malformations are associated with the use of the larvicide pyriproxyfen. In addition to evidence from recent studies that connect the neurological disorders in infants to previous infection of pregnant women by ZIKV, it is worth noting that in the epidemic in French Polynesia, in 2013-2014, in which this larvicide was not used, microcephaly cases were found in a retrospective study 11 , and that in the city of Recife, one of the areas most affected by the ZIKV epidemic and with the highest number of microcephaly cases 9 , the referred larvicide was also not used. The transmission of ZIKV in Brazil raises many concerns: the social and ecological context in the Americas, particularly in Brazil, promotes the spread of arboviruses and the occurrence of severe cases associated with viral co-circulation; the current strategy in handling the vector in most areas has proven ineffective; climate and environmental conditions are appropriate for the activity and reproduction of the vector; cities crowded with intense flow of travelers makes Brazil not only vulnerable to large outbreaks but also a dispersal point of cases for the rest of the world.
Despite the economic and political difficulties faced by the country, research groups and institutions are working hard in facing this huge challenge to global public health. Several studies have been suggested and are underway to answer basic questions about this emerging disease, but little is known. A scientific agenda was proposed in a joint venture between the Ministry of Science and Technology and the Oswaldo Cruz Foundation, advising six broad research areas, from the production of knowledge on the infection, disease and outcomes, development of diagnostic tests, clinical management protocols and development of vaccines, to interventions on the health-care system 12 These are just some of the many questions to be answered. The apparent rapid expansion of the ZIKV transmission area in Brazil must now be seen as an emerging public health challenge, not only for the country but also for all America. Several epidemiological studies are being conducted or are in the planning stages in the country, with the aim of knowing the disease from a clinical, epidemiological, and laboratorial point of view. Animal models have been suggested to investigate how the virus affects the nervous tissue; other research groups seek biochemical pathways and proteins in the central nervous system that are targets of congenital infection and potential therapeutic loci.
There are efforts underway for the synthesizing of a protective and immunotherapeutic vaccine, in addition to conducting sensitive and specific serological reactions, with little cross-reactivity to other flaviviruses.
PERSPECTIVES
Faced with the challenge of handling a still unknown disease and with few diagnostic tools available, many actions have been proposed, including: strengthening the Unified Health System (SUS) and the complex epidemiological surveillance system to detect suspected cases; strengthening the support and assistance network to affected patients; organizing a network of laboratories with well-defined criteria for the investigation of suspected cases using PCR reaction until serological tests are available; investing heavily in vector control, training of health professionals and in community participation to fight off the epidemic; using known larvicides and insecticides with technical rigor, as well as alternative substances previously assessed by the National Health Surveillance Agency (ANVISA) which showed proven efficacy, as well as using biological control methods that do not harm the environment; improving the health information systems of the Informatics Department of the Unified Health System (DATASUS) and the Mortality Information System (SIM), the Live Births Information System (SINASC), the Information System for Notifiable Diseases (SINAN), and the Hospital Information System (SIH) to continue providing reference information to guide specific epidemiological investigations.
In the research area, research efforts should be coordinated with the integration of groups to streamline and increase the response speed on various aspects of the disease in the country. Therefore, it is suggested that research protocols in place are disseminated to facilitate the comparison of results; simplifying the exchange of biological materials and partial research results; and proposing and conducting multicentric studies. Strengthening the Department of Science and Technology (DECIT) to formulate, implement, and prioritize the research agenda that is of national interest.
The Brazilian Collective Health Association (Abrasco) can promote the integration of efforts, stimulating, mediating, and assisting in the formation of research networks that act in solidarity, increasing investment and streamlining endeavors and competencies. It can and should, being a scientific association with great respectability in the country, contribute to the dialogue between academia, particularly the groups involved with the research, the population, and the government, disseminating the results of studies, informing policies and stimulating their immediate application.
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